The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical and prognostic implications of the TCR repertoire in leiomyosarcoma.
 
John Wang
No Relationships to Disclose
 
Rusul Al-Marayaty
No Relationships to Disclose
 
Juliana Ng
No Relationships to Disclose
 
Meghan Lynch
No Relationships to Disclose
 
Nourhane Al Akoum
No Relationships to Disclose
 
Farres Obeidin
No Relationships to Disclose
 
Jian-Jun Wei
No Relationships to Disclose
 
Demirkan Gursel
No Relationships to Disclose
 
Borislav Alexiev
No Relationships to Disclose
 
Akhil Chawla
No Relationships to Disclose
 
Jeffrey Wayne
Honoraria - StringWorks Therapeutics
Speakers' Bureau - StringWorks Therapeutics
 
Vinai Gondi
Honoraria - UpToDate
Research Funding - ImmunoChem Therapeutics LLC via NIH STTR grant
 
John Hayes
No Relationships to Disclose
 
Fahad Faruqi
No Relationships to Disclose
 
Terrance Peabody
No Relationships to Disclose
 
Samer Attar
No Relationships to Disclose
 
Pedro Hermida de Viveiros
Honoraria - Deciphera; SpringWorks Therapeutics
Research Funding - Boehringer Ingelheim (Inst)
 
Seth Pollack
Consulting or Advisory Role - AADi; Adaptimmune; Apexigen; Bayer; Boehringer Ingelheim; Daiichi Sankyo; Deciphera; Epizyme; GlaxoSmithKline; Ipsen; Obsidian Therapeutics; Rain Therapeutics; Replimune; Sensei Biotherapeutics; SpringWorks Therapeutics; T-knife Therapeutics
Speakers' Bureau - Deciphera; SpringWorks Therapeutics
Research Funding - Obsidian Therapeutics (Inst)